Impact of Abernathy malformation on pulmonary circulatory hemodynamics in a univentricular heart
Vinoth Doraiswamy, Kothandam Sivakumar
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, Tamil Nadu, India
How to cite this article: Doraiswamy V, Sivakumar K. Impact of Abernathy malformation on pulmonary circulatory hemodynamics in a univentricular heart. Ann Pediatr Card 2017;10:90-1
How to cite this URL: Doraiswamy V, Sivakumar K. Impact of Abernathy malformation on pulmonary circulatory hemodynamics in a univentricular heart. Ann Pediatr Card [serial online] 2017 [cited 2022 Aug 12];10:90-1. Available from: https://www.annalspc.com/text.asp?2017/10/1/90/197071
Sir,
An 18-month-old male child weighing 9 kg with oxygen saturations of 78% was diagnosed to have heterotaxy, left isomerism, dextrocardia, right azygos continuation of the inferior vena cava, common atrioventricular valve, single ventricle, and pulmonary atresia. Cardiac catheterization demonstrated a communication from the renal portion of inferior vena cava to the final common splenic vein arising from multiple splenunculi [Figure 1] and [Video 1]. The pulmonary artery pressures were recorded to be 15 mmHg through an end-hole catheter through the ductus arteriosus. There were no secondary effects attributable to this Abernathy malformation, and hence, it was not closed. He underwent total cavopulmonary (Kawashima) shunt uneventfully.
Figure 1: Selective catheter injection into Abernathy vein shows filling of portal vein formed by superior mesenteric and splenic veins. Following total cavopulmonary shunt surgery, the portal vein blood spills into the inferior vena cava
After 2 years, he developed increasing cyanosis and worsening hypoxia. Cardiac catheterization showed elevated pulmonary artery pressures of 20 mmHg with flow reversal through the Abernathy vein. There were no other new venovenous collaterals or pulmonary arteriovenous malformations. Oral sildenafil was given for 1 year to reduce the pulmonary artery pressures. Computed tomogram showed the vessel diameter to be 10 mm [Figure 2] and [Video 2]. Closure of the Abernathy collateral with 12–10 HeartR duct occluder (Lifetech Scientific, Shenzhen, PRC) through a femoral venous long sheath resulted in improvement of oxygen saturations to 92% without further increase of pulmonary artery pressures [Figure 3] and [Video 3]. Hemodynamic study after 18 months showed reduction of pulmonary artery pressures to 15 mmHg.
Figure 2: Computed tomogram with maximum intensity projection with and without liver overlay demonstrates the Abernathy venous channel from the inferior vena cava to the splenic vein
Abernathy malformation, a congenital portosystemic shunt, is rarely associated with congenital heart defects.[1],[2],[3] Since vitelline veins do not directly contribute to cardiac chamber morphogenesis, Abernathy malformations are rare in cardiac defects. Our patient had polysplenia, dextrocardia with single ventricle physiology. Abernathy malformation may alter the pulmonary vasculature, thereby affecting a univentricular circulation.[4],[5]
Single ventricle after total cavopulmonary (Kawashima) shunt in the presence of Abernathy malformations poses a peculiar hemodynamics [Figure 4]. In a normal circulation, the usual transpulmonary gradient from pulmonary arteries to left atrium is 5–6 mmHg, and the usual gradient from portal vein to the hepatic veins across the liver parenchyma is 1–2 mmHg. When inferior vena cava is connected to pulmonary artery, the Abernathy vein acts as a decompressing collateral and the higher transpulmonary gradient usually tends to drive blood toward the portal circulation and cause hypoxia.[5] However, any flow reversal, even if occurring for brief periods, results in unmetabolized toxic substances in the postprandial state from the mesenteric circulation to enter the pulmonary circulation, leading to either increase in pulmonary vascular resistance or creation of arteriovenous malformations. The rise in pulmonary artery pressures and fall in oxygen levels in our patient were secondary to this peculiar physiology.
Figure 4: Cartoon explaining hemodynamics of single ventricle with Abernathy malformation in our patient before and after surgery. Before the surgery, vena caval and atrial pressures were 6 mmHg less than pulmonary artery pressures and portal blood reversed through the Abernathy vein (Abernethy malformation) due to transhepatic gradient. After surgery, vena caval and pulmonary artery pressures were 20 mmHg. Since the transpulmonary gradient was higher than transhepatic gradient, Abernathy vein acted as a decompressing vein and led to hypoxia
Percutaneous closure of Abernathy malformation led to immediate reduction of the bypass of caval blood to the portal circulation and resulted in improved oxygen levels. As the intestinal unmetabolized products could no longer reach the lung bed, the high pulmonary artery pressures also normalized. Even though portal vein pressures could be assessed by wedging an end-hole catheter in the hepatic veins, it was not done in our patient. He continues to have oxygen saturations of 90%, 2 years following the closure of Abernathy vein. He will be planned for completion of Fontan surgery by routing the hepatic veins to the pulmonary artery through an extracardiac conduit in future if there is a fall in his oxygen saturations.
Morgan G, Superina R. Congenital absence of the portal vein: Two cases and a proposed classification system for portasystemic vascular anomalies. J Pediatr Surg 1994;29:1239-41.
Ratnasamy C, Kurbegov A, Swaminathan S. Cardiac anomalies in the setting of the Abernethy malformation of the portal vein. Cardiol Young 2007;17:212-4.
McElhinney DB, Marx GR, Newburger JW. Congenital portosystemic venous connections and other abdominal venous abnormalities in patients with polysplenia and functionally univentricular heart disease: A case series and literature review. Congenit Heart Dis 2011;6:28-40.
Correspondence Address: Kothandam Sivakumar Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, Tamil Nadu India
Source of Support: None, Conflict of Interest: None
Search Pubmed for
